Search

Your search keyword '"Scott, Véronique"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Scott, Véronique" Remove constraint Author: "Scott, Véronique"
39 results on '"Scott, Véronique"'

Search Results

2. Supplementary Tables S1-S11 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

3. Supplementary Figures S1-S24 from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

4. Data from Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

5. Abstract 6570: Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

6. Data from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

7. Supplementary Table 1 from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

8. Supplementary Methods from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

9. Supplementary Table 2 from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

10. Supplementary Figure Legend from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

11. Supplementary Figures 1 - 7 from Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

12. Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer

13. Comparative Genomic Profiling of Second Breast Cancers following First Ipsilateral Hormone Receptor–Positive Breast Cancers

14. Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

17. Whole exome sequencing of rare aggressive breast cancer histologies

21. Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer

22. Ribosomal RNA 2′ O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer

23. Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis

25. Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

26. Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

27. Combinatorial expression of microtubule-associated EB1 and ATIP3 biomarkers improves breast cancer prognosis

30. Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy

31. Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patients

32. Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis

37. <TOGGLE>In situ</TOGGLE> T-cell responses in a primary regressive melanoma and subsequent metastases: A comparative analysis

38. Erratum: Ribosomal RNA 2' O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.

39. COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2 -negative Breast Cancer Patients.

Catalog

Books, media, physical & digital resources